Taxonomy

Accelerating Genetic Therapy for CMT4B1: A CMTA Research Update

With CMTA’s support, researchers at San Raffaele Scientific Institute in

CMTA’s $300K Investment in CRISPR for CMT2A

The Charcot-Marie-Tooth Association (CMTA) is investing $300,000 in a groundbreaking

What’s New in CMT Research and Care? A 2025 Update Published by CMTA-STAR Advisory Board Member Davide Pareyson, MD

CMTA Strategy To Accelerate Research (CMTA-STAR) Advisory Board member and

CMTA Announces New Center of Excellence at UPMC in Pittsburgh, Pennsylvania

The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of

CMTA Fuels Breakthrough Imaging Research to Address CMT2A’s Cellular Weakness

The Charcot-Marie-Tooth Association (CMTA) announces a $90,860 investment in a

CMTA Spring 2025 Report | EMPOWERING INDEPENDENCE: SMALL TOOLS, BIG IMPACT

VIEW IN BROWSER The Spring 2025 CMTA Report focuses on

Episode 3 of the Simply CMT Podcast with Dr. Katherine Forsey

Join us as we talk with Dr. Katherine Forsey, CMTA’s

CMTA Films Presents Jonah Berger

CMTA Films presents Jonah Berger, CMTA’s National Youth Programs Manager,

Actio Biosciences Doses First Participant in Phase I Clinical Trial | Future Phase Ib Clinical Trial to Focus on CMT2C

CMTA-STAR Alliance Partner Actio Biosciences has announced that the first

CMTA Partners with BILLY Footwear

The Charcot-Marie-Tooth Association (CMTA) is excited to announce a new